![fda statement bpc-157 not approved fda.gov Safety and Efficacy of and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] BPC-157 Legal Status: FDA Regulations](https://www.preprints.org/frontend/picture/ms_xml/manuscript/ae34a89ce81cb490bff0445a6ef28159/preprints-206876-g004.png)
fda statement bpc-157 not approved fda.gov Safety and Efficacy of and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] BPC-157 Legal Status: FDA Regulations
Description
A 2011 mechanism paper by Chang and colleagues in Journal of Applied Physiology demonstrated that BPC-157 promotes tendon fibroblast outgrowth, supports fibroblast survival under oxidative stress, and facilitates cell migration through the FAK-paxillin signaling pathway a pathway central to cell adhesion and movement
![fda statement bpc-157 not approved fda.gov Safety and Efficacy of and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] BPC-157 Legal Status: FDA Regulations](https://jwchvngzvwbtirpreubk.supabase.co/storage/v1/object/public/blog-images/bpc-157-legal-status.webp)
While the trials reported minimal injection site issues, proper technique remains important for safety
![fda statement bpc-157 not approved fda.gov Safety and Efficacy of and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] BPC-157 Legal Status: FDA Regulations](https://amaneciahealth.com/wp-content/uploads/2025/12/FullColor_Horizontal_Large.png)
In addition, vitamin B12 supplements are widely available to the public and are among the most popular vitamin supplements used today
![fda statement bpc-157 not approved fda.gov Safety and Efficacy of and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] BPC-157 Legal Status: FDA Regulations](https://www.novomedlink.com/semaglutide/patient-safety/difference-fda-approved-compounded-semaglutide/_jcr_content/root/slab_822594890/content/container/container/image.img.svg/1771519199438/3-0-impurities-infographic.svg)
Current evidence remains exploratory, with no approved human applications, positioning the neurological research surrounding BPC-157 and neural repair as preliminary but consistently documented across animal models
![fda statement bpc-157 not approved fda.gov Safety and Efficacy of and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] BPC-157 Legal Status: FDA Regulations](https://assets.cureus.com/uploads/figure/file/2070336/article_river_aab270b0633a11f1ab834d2c0220ad2c-mon-9-2.png)
In the controls, there were no significant changes compared to the 1st week
![fda statement bpc-157 not approved fda.gov Safety and Efficacy of and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] BPC-157 Legal Status: FDA Regulations](https://www.mdpi.com/pharmaceutics/pharmaceutics-18-00625/article_deploy/html/images/pharmaceutics-18-00625-g002-550.jpg)
Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance
![fda statement bpc-157 not approved fda.gov Safety and Efficacy of and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] BPC-157 Legal Status: FDA Regulations](https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png)
